Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPG.L Regulatory News (PPG)

  • There is currently no data for PPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further re Capital Reorganisation

6 Nov 2020 11:00

RNS Number : 5274E
Plutus PowerGen PLC
06 November 2020
 

6 November 2020

PLUTUS POWERGEN PLC

("Plutus", the "Group" or the "Company")

Further re Capital Reorganisation

Further to the announcements released by the Company on 9 October 2020 and 3 November 2020, the Company provides an update on the timetable and process of the Capital Reorganisation. As part of the previously announced Proposals the Company is sub-dividing every Existing Ordinary Share into one New Ordinary Share and nine Deferred Shares.

At the general meeting of the Company held on 3 November 2020, shareholders approved, inter alia, the Capital Reorganisation. Following the passing of the Resolutions the Company's 872,534,994 Existing Ordinary Shares will be sub-divided into one New Ordinary Share of 0.01 pence each and nine Deferred Shares of 0.01 pence each. As announced on 3 November 2020, the Record Date for the Capital Reorganisation is 6.00 p.m. on 6 November 2020.

Application has been made for admission of the 872,534,994 New Ordinary Shares in issue immediately following the Capital Reorganisation to trading on AIM ("Admission"). It is expected that Admission will take place and that trading in the New Ordinary Shares will commence at 8.00 a.m. on 9 November 2020.

Following the Capital Reorganisation and Admission the number of existing ordinary shares in issue, and held by each Shareholder, will not change. It is simply the nominal value of the existing ordinary shares which will change.

The Deferred Shares will have no rights and the Company will not issue any certificates or credit CREST accounts in respect of them. The Deferred Shares will not be admitted to trading on AIM.

As previously announced the Proposals remain conditional on confirmation of the Reduction of Capital by the Court. The Hearing Date to confirm the Reduction of Capital is expected to take place on 24 November 2020 and the Reduction of Capital is expected to become effective between 25 November and 9 December 2020. In particular, the Placing and Debt Capitalisation remain conditional on the Reduction of Capital being confirmed by the Court, the Demerger becoming effective and admission of the Placing Shares and Debt Capitalisation Shares.

A timetable of principal events with regards to the Proposals was set out in the announcement released by the Company on 3 November 2020.

Further announcements will be made in due course.

Definitions in this announcement are consistent with those set out in the circular issued to Shareholders of the Company on 9 October 2020, a copy of which is available on the investor section of the Company's current website (http://www.plutuspowergenplc.com).

For further information, please contact:

Plutus PowerGen PLC

Charles Tatnall, Executive Chairman

James Longley, Interim CEO and Finance Director

 

Tel: +44 (0) 20 8720 6562

 

Allenby Capital (Nominated Adviser and Joint Broker)

Nick Athanas

Nick Naylor

James Hornigold

 

Tel: +44 (0)20 3328 5656

Turner Pope Investments (TPI) Limited (Joint Broker)

Andy Thacker

 

  Tel: +44 (0) 20 3657 0050

St Brides Partners Limited (Financial PR)

Cosima Akerman

Tel: +44 (0)20 7236 1177

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURKKABQKBDDODK
Date   Source Headline
15th Oct 20121:00 pmRNSDisposal
10th Oct 20127:30 amRNSSuspension - IPSO Ventures Plc
10th Oct 20127:30 amRNSStatement re. Suspension
29th Aug 20127:00 amRNSHolding(s) in Company
10th Aug 20127:00 amRNSDirector/PDMR Shareholding
3rd Aug 201212:40 pmRNSReplacement - Director Shareholding
3rd Aug 20127:00 amRNSDirector/PDMR Shareholding
15th Jun 20127:00 amRNSHolding(s) in Company
18th Apr 20127:00 amRNSDirector/PDMR Shareholding
29th Feb 20127:00 amRNSTotal Voting Rights
8th Feb 20127:00 amRNSIssue of equity, directors' shareholdings and TVR
23rd Jan 20127:01 amRNSHalf Yearly Report
17th Jan 20124:30 pmRNSHolding(s) in Company
30th Nov 20117:00 amRNSTotal Voting Rights
18th Nov 20117:00 amRNSIssue of Equity
14th Nov 20112:00 pmRNSDirector/PDMR Shareholding
1st Nov 20114:20 pmRNSChange of Registered Office
24th Oct 20117:00 amRNSAIM Rule 17 Disclosures
12th Oct 20117:00 amRNSIPSol Energy successful fund raising
3rd Oct 20115:15 pmRNSHolding(s) in Company
30th Sep 201110:00 amRNSTotal Voting Rights
30th Sep 20119:00 amRNSHolding(s) in Company
22nd Sep 20111:50 pmRNSHolding(s) in Company
15th Sep 20112:15 pmRNSEU grants approval for Buccolam
9th Sep 20111:00 pmRNSResult of AGM
25th Aug 20111:35 pmRNSIssue of Equity and Director Dealings
19th Aug 20117:00 amRNSFinal Results
8th Aug 20117:00 amRNSDirectorate Changes
12th Jul 20117:00 amRNSTermination of Loughborough University agreement
7th Jul 201110:35 amRNSCompletion of placing to raise £195,000
1st Jul 20117:00 amRNSTherakind Product Update
29th Jun 20111:05 pmRNSResult of General Meeting
27th Jun 20117:00 amRNSFurther re General Meeting
24th Jun 20117:00 amRNSHolding(s) in Company
22nd Jun 20114:58 pmRNSHolding(s) in Company
22nd Jun 20117:00 amRNSShareholding in Biocroi
13th Jun 20113:50 pmRNSProposed Placing to raise £195,000/Notice of GM
25th May 20115:10 pmRNSHolding(s) in Company
24th May 20117:00 amRNSCambridge Meditech agreement with Lantor (UK)
25th Mar 20117:00 amRNSTrading update
11th Feb 20117:00 amRNSHolding(s) in Company
8th Feb 20111:30 pmRNSHolding(s) in Company
26th Jan 20113:30 pmRNSHolding(s) in Company
5th Jan 20117:00 amRNSHalf Yearly Report
8th Oct 20103:15 pmRNSDirector/PDMR Shareholding
8th Oct 20108:00 amRNSDirectorate Change
13th Sep 20107:00 amRNSAllotment of Adviser Shares
10th Sep 201012:30 pmRNSResult of AGM
27th Aug 201012:20 pmRNSResult of General Meeting
20th Aug 20107:00 amRNSPosting of Annual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.